Signios Bio Launches with AI-Driven Bioinformatics and Advanced Multiomics Platform to Power the Future of Precision Medicine and Drug Discovery
FOSTER CITY, California, APRIL 10, 2025 — Signios Biosciences (“Signios Bio”), a science-first biotechnology company at the forefront of multiomics and AI-powered bioinformatics, today announced its rebranding from its previous identity as the US based research division of MedGenome Inc. This milestone marks a new era, better positioning the brand in the US on its […]